Search
Showing results for "1"
Research
Antenatal services for Aboriginal women: the relevance of cultural competenceDue to persistent significantly poorer Aboriginal perinatal outcomes, the Women's and Newborns' Health Network, require a comprehensive appraisal...
News & Events
Avid cyclist Theo Grant completes Everesting eventWA teenager Theo Grant has been living with type 1 diabetes since he was two-years-old, but the condition hasn't stopped him from setting big goals
News & Events
School well equipped to deal with diabetesMeet Nathan, Hayley and Aiden. They all live with Type 1 Diabetes (T1D) and attend the same primary school.
News & Events
Ads clinic updateThe Perth Children’s Hospital (PCH) Adolescent Diabetes Service (ADS) clinics have had several updates thanks to your feedback, including the introduction of “Welcome to Ads group sessions” for teenagers.
News & Events
Research finds pumps deliver better long-term blood glucose controlNew research from the Children’s Diabetes Centre at The Kids Research Institute Australia has found children who use an insulin pump to manage their type 1 diabetes have better long-term blood glucose control than those on insulin injections.
Research
'If I Wanted to Have More Opportunities and Go to a Better School, I Just Had to Get Used to It’The experiences of 32 male Aboriginal students from regional and remote towns and communities while they attended a metropolitan boarding school...
The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.
Research
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.
News & Events
Hybrid-Closed loop system improves quality of lifeNew Insulin delivery technology improves quality of life and offers better glucose control in young people living with type 1 diabetes.